» Articles » PMID: 33143012

Localised Grey Matter Atrophy in Multiple Sclerosis and Clinically Isolated Syndrome-A Coordinate-Based Meta-Analysis, Meta-Analysis of Networks, and Meta-Regression of Voxel-Based Morphometry Studies

Overview
Journal Brain Sci
Publisher MDPI
Date 2020 Nov 4
PMID 33143012
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atrophy of grey matter (GM) is observed in the earliest stages of multiple sclerosis (MS) and is associated with cognitive decline and physical disability. Localised GM atrophy in MS can be explored and better understood using magnetic resonance imaging and voxel-based morphometry (VBM). However, results are difficult to interpret due to methodological differences between studies.

Methods: Coordinate-based analysis is a way to find the reliably observable results across multiple independent VBM studies. This work uses coordinate-based meta-analysis, meta-analysis of networks, and meta-regression to summarise the evidence from voxel-based morphometry of regional GM hanges in patients with MS and clinically isolated syndrome (CIS), and whether these measured changes are relatable to clinical features.

Results: Thirty-four published articles reporting forty-four independent experiments using VBM for the assessment of GM atrophy between MS or CIS patients and healthy controls were identified. Analysis identified eight clusters of consistent cross-study reporting of localised GM atrophy involving both cortical and subcortical regions. Meta-network analysis identified a network-like pattern indicating that GM loss occurs with some symmetry between hemispheres. Meta-regression analysis indicates a relationship between disease duration or age and the magnitude of reported statistical effect in some deep GM structures.

Conclusions: These results suggest consistency in MRI-detectible regional GM loss across multiple MS studies, and the estimated effect sizes and symmetries can help design prospective studies to test specific hypotheses.

Citing Articles

Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.

Meijboom R, York E, Kampaite A, Harris M, White N, Valdes Hernandez M PLoS One. 2023; 18(7):e0288967.

PMID: 37506096 PMC: 10381059. DOI: 10.1371/journal.pone.0288967.


Impaired lung function in multiple sclerosis: a single-center observational study in 371 persons.

Murrieta-Alvarez I, A Fernandez-Gutierrez J, Perez C, Leon-Pena A, Reyes-Cisneros O, Benitez-Salazar J Neurol Sci. 2023; 44(12):4429-4439.

PMID: 37410269 DOI: 10.1007/s10072-023-06914-6.


Effect of geometric distortion correction on thickness and volume measurements of cortical parcellations in 3D T1w gradient echo sequences.

Thaler C, Sedlacik J, Forkert N, Stellmann J, Schon G, Fiehler J PLoS One. 2023; 18(4):e0284440.

PMID: 37058493 PMC: 10104308. DOI: 10.1371/journal.pone.0284440.


Assessing Age-Related Gray Matter Differences in Young Adults with Voxel-Based Morphometry: The Effect of Field Strengths.

Su F, Chen J, Chen C, Huang Y, Peng S Brain Sci. 2021; 11(4).

PMID: 33807399 PMC: 8066590. DOI: 10.3390/brainsci11040447.

References
1.
Chiang F, Wang Q, Yu F, Romero R, Huang S, Fox P . Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis. Clin Radiol. 2019; 74(10):816.e19-816.e28. PMC: 6757337. DOI: 10.1016/j.crad.2019.07.005. View

2.
Geurts J, Barkhof F . Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008; 7(9):841-51. DOI: 10.1016/S1474-4422(08)70191-1. View

3.
Koskimaki F, Bernard J, Yong J, Arndt N, Carroll T, Lee S . Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment. PLoS One. 2018; 13(12):e0209326. PMC: 6303064. DOI: 10.1371/journal.pone.0209326. View

4.
Fisher E, Lee J, Nakamura K, Rudick R . Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol. 2008; 64(3):255-65. DOI: 10.1002/ana.21436. View

5.
Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G . Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry. 2014; 85(12):1386-95. PMC: 4251183. DOI: 10.1136/jnnp-2014-307712. View